NCT04668521TerminatedNot Applicable
Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Sponsor
- Aspira Women's Health
- Enrollment
- 215
- Locations
- 1
- Primary Endpoint
- OVA360
Study Overview
Brief Summary
The objective of this project is to validate a next-generation assay that utilizes both the protein biomarkers of our already established ovarian cancer risk assessment combined with a molecular profile in both germline and early somatic detection.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
OVA360
Time Frame: 12 months
Identify the molecular key driver of Ovarian cancer and develop a diagnostic test for early Ovarian cancer detection
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal StudyBRCA1/2 NegativeNCT02514499Abramson Cancer Center at Penn Medicine350
Terminated
Not Applicable
A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline VariantsAdnexal MassNCT04487405Aspira Women's Health721
Active, not recruiting
Not Applicable
Gait Spine Functional Evaluation ProtocolSpine DiseaseGaitNCT06400680IRCCS Eugenio Medea20
Completed
Not Applicable
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube CancersFallopian Tube CancerPeritoneal NeoplasmsEpithelial Ovarian CancerNCT00086567National Cancer Institute (NCI)119
Unknown
Not Applicable
NECROtizing Soft Tissue Infections and Their Scoring SystemNecrosisNCT05224817Methodist Health System1,010